Bruker Corporation (BRKR) News
Filter BRKR News Items
BRKR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BRKR News Highlights
- For BRKR, its 30 day story count is now at 4.
- Over the past 16 days, the trend for BRKR's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about BRKR are NMR.
Latest BRKR News From Around the Web
Below are the latest news stories about BRUKER CORP that investors may wish to consider to help them evaluate BRKR as an investment opportunity.
Here's Why Investors Should Retain Bruker (BRKR) Stock NowInvestors remain optimistic about Bruker (BRKR) due to the strength of the BSI BioSpin and CALID groups. |
Bruker (BRKR) Installs First 1.2 GHz NMR at Ohio UniversityBruker (BRKR) 1.2 GHz AVANCE NMR spectrometer is cutting-edge equipment capable of performing high-resolution liquid and solid-state NMR studies. |
Bruker Announces First 1.2 GHz NMR Installation in the United States at The Ohio State University - Funded by the U.S. National Science FoundationCOLUMBUS, Ohio, December 19, 2023--Bruker Corporation, the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions for life and materials research, today announced the successful installation of a 1.2 Gigahertz (GHz) NMR system at the National Gateway Ultrahigh Field NMR Center (https://gateway-nmr.osu.edu/) at The Ohio State University. |
Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?While Bruker Corporation ( NASDAQ:BRKR ) might not be the most widely known stock at the moment, it saw a significant... |
Accelerate Diagnostics (AXDX) Expands in In Vitro DiagnosticsAccelerate Diagnostics' (AXDX) Arc system eliminates the need for overnight culture incubation, drastically reducing the wait time for identification results. |
Bruker's (BRKR) New Collaboration to Use MALDI Biotyper SystemBruker (BRKR) and Accelerate Diagnostics are set to work together to bring rapid, automated microbial identification directly from positive blood culture samples. |
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and quality agreement with Bruker Corporation (NASDAQ: BRKR), the provider of the market-leading MALDI Biotyper system for microbial identification. This agreement enables both companies to validate the use of Accelerate Diagnostics' Arc™ system, an innovative, automated positive blood culture sample preparation platform, with Bruker's MALDI Biotyper® s |
Bruker Announces Quarterly DividendBILLERICA, Mass., November 20, 2023--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on December 15, 2023 to stockholders of record as of December 1, 2023. |
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare ConferenceBILLERICA, Mass., November 07, 2023--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2023 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the Company on Tuesday, November 14, 2022 at 8:30 AM GMT (3:30 AM Eastern Time). |
Bruker (BRKR) Q3 Earnings and Revenues Top, '23 Sales View UpBruker (BRKR) delivers better-than-expected earnings and revenues in the third quarter of 2023. |